Thomas Klein

20.5k total citations · 2 hit papers
446 papers, 15.7k citations indexed

About

Thomas Klein is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Thomas Klein has authored 446 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Immunology, 93 papers in Molecular Biology and 85 papers in Pharmacology. Recurrent topics in Thomas Klein's work include Legionella and Acanthamoeba research (77 papers), Diabetes Treatment and Management (70 papers) and Cannabis and Cannabinoid Research (60 papers). Thomas Klein is often cited by papers focused on Legionella and Acanthamoeba research (77 papers), Diabetes Treatment and Management (70 papers) and Cannabis and Cannabinoid Research (60 papers). Thomas Klein collaborates with scholars based in United States, Germany and China. Thomas Klein's co-authors include Herman Friedman, Catherine Newton, Yoshimasa Yamamoto, Cathy Newton, Rolf M. Nüsing, Michael Mark, R Widen, C. Newton, Izabella Perkins and Herman Friedman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Thomas Klein

422 papers receiving 15.2k citations

Hit Papers

Cannabinoid-based drugs as anti-inflammatory therapeutics 2005 2026 2012 2019 2005 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cannabinoid-based drugs as anti-inflammatory therapeutics
    2005 566 citations Thomas Klein profile →
  2. Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors
    2011 494 citations Thomas Klein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Klein United States 66 4.8k 3.5k 3.0k 2.8k 2.1k 446 15.7k
Mark G. Currie United States 63 1.7k 0.3× 4.6k 1.3× 751 0.2× 1.5k 0.5× 1.3k 0.6× 219 17.0k
Derek W. Gilroy United Kingdom 60 2.4k 0.5× 5.1k 1.5× 588 0.2× 5.3k 1.9× 417 0.2× 143 17.2k
Michael Emerson United Kingdom 29 1.3k 0.3× 5.9k 1.7× 715 0.2× 1.6k 0.6× 2.4k 1.1× 55 19.2k
Toru Kita Japan 86 1.7k 0.4× 9.3k 2.6× 2.7k 0.9× 7.0k 2.5× 1.6k 0.7× 480 28.4k
Carol Kilkenny United Kingdom 11 1.2k 0.2× 5.1k 1.4× 654 0.2× 1.4k 0.5× 2.2k 1.1× 12 17.6k
Mauro Martins Teixeira Brazil 85 1.5k 0.3× 10.5k 3.0× 1.0k 0.3× 9.2k 3.3× 1.1k 0.5× 768 32.6k
Hubert Kolb Germany 72 771 0.2× 4.4k 1.3× 4.6k 1.5× 4.6k 1.7× 470 0.2× 309 17.6k
Jing Liu China 65 1.1k 0.2× 9.6k 2.7× 841 0.3× 2.1k 0.8× 711 0.3× 1.2k 22.9k
Prakash Nagarkatti United States 72 3.4k 0.7× 6.0k 1.7× 651 0.2× 4.7k 1.7× 803 0.4× 406 16.1k
Steven B. Abramson United States 89 7.5k 1.5× 7.7k 2.2× 435 0.1× 4.6k 1.7× 927 0.4× 309 29.9k

Countries citing papers authored by Thomas Klein

Since Specialization
Citations

This map shows the geographic impact of Thomas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Klein more than expected).

Fields of papers citing papers by Thomas Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Klein. The network helps show where Thomas Klein may publish in the future.

Co-authorship network of co-authors of Thomas Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Klein. A scholar is included among the top collaborators of Thomas Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Klein. Thomas Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nyström, Thomas, et al.. (2024). The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice. Cardiovascular Diabetology. 23(1). 88–88. 12 indexed citations
4.
Klein, Thomas, Robert Augustin, & Anita M. Hennige. (2023). Perspectives in weight control in diabetes – Survodutide. Diabetes Research and Clinical Practice. 207. 110779–110779. 11 indexed citations
5.
Lietzau, Grażyna, Hiranya Pintana, Thomas Klein, et al.. (2021). A High-Fat Diet Increases Activation of the Glucagon-Like Peptide-1-Producing Neurons in the Nucleus Tractus Solitarii: an Effect that is Partially Reversed by Drugs Normalizing Glycemia. Cellular and Molecular Neurobiology. 42(6). 1995–2002. 3 indexed citations
6.
Pintana, Hiranya, Martin Larsson, Thomas Nyström, et al.. (2020). Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery. Diabetes. 69(9). 1961–1973. 16 indexed citations
7.
Lietzau, Grażyna, Giulia Magni, Ján Kehr, et al.. (2020). Dipeptidyl peptidase-4 inhibitors and sulfonylureas prevent the progressive impairment of the nigrostriatal dopaminergic system induced by diabetes during aging. Neurobiology of Aging. 89. 12–23. 19 indexed citations
8.
Korbut, Anton I., Н. П. Бгатова, Natalia A. Muraleva, et al.. (2020). SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes. International Journal of Molecular Sciences. 21(8). 2987–2987. 85 indexed citations
9.
Batchu, Sri Nagarjun, Harmandeep Kaur, Veera Ganesh Yerra, et al.. (2020). Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker–Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19. Diabetes. 70(3). 759–771. 21 indexed citations
10.
Wang, Xiaoyu, Michael Hausding, Shih‐Yen Weng, et al.. (2017). Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. Antioxidants and Redox Signaling. 28(2). 87–109. 66 indexed citations
11.
Steven, Sebastian, Michael Hausding, Swenja Kröller‐Schön, et al.. (2015). Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia. Basic Research in Cardiology. 110(2). 6–6. 99 indexed citations
12.
13.
Klein, Thomas, et al.. (2007). Der langfristige Wandel partnerschaftlicher Lebensformen im Spiegel des Mikrozensus. Social Science Open Access Repository (GESIS – Leibniz Institute for the Social Sciences). 433–447. 13 indexed citations
14.
Klein, Thomas. (2003). Arbeitslosengeld, Arbeitslosenhilfe und Wohngeld im Kampf gegen Verarmung und Abstieg bei Arbeitslosigkeit : Ergebnisse einer mikroanalytischen Untersuchung zur Auffangwirkung einkommensabhängiger Sozialleistungen. Mitteilungen aus der Arbeitsmarkt- und Berufsforschung. 20(3). 351–367. 1 indexed citations
15.
Newton, Catherine, et al.. (2001). Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. European Journal of Pharmacology. 423(2-3). 235–241. 75 indexed citations
16.
Newton, Catherine, et al.. (2000). Tumor Necrosis Factor Induces Resistance of Macrophages to Legionella pneumophila Infection. Proceedings of The Society for Experimental Biology and Medicine. 224(3). 191–196. 33 indexed citations
17.
Klein, Thomas. (1998). Der Heimeintritt alter Menschen und Chancen seiner Vermeidung Ergebnisse einer Repräsentativerhebung in den Einrichtungen der stationären Altenhilfe. Zeitschrift für Gerontologie und Geriatrie. 31(6). 407–416. 6 indexed citations
18.
Breyer, Friedrich, et al.. (1997). Kosten und Nutzen ambulanter Psychoanalyse in Deutschland. Gesundheitsökonomie & Qualitätsmanagement. 2(3). 59–73. 4 indexed citations
19.
Klein, Thomas. (1991). Keine Opposition. Nirgends? : Linke in Deutschland nach dem Sturz des Realsozialismus. 1 indexed citations
20.
Nowotny, A., Didier Blanchard, Catherine Newton, et al.. (1987). Interferon Induction by Endotoxin-Derived Nontoxic Polysaccharides. Journal of Interferon Research. 7(4). 371–378. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark G. Currie Breakdown of academic impact, for papers by Derek W. Gilroy Breakdown of academic impact, for papers by Michael Emerson Breakdown of academic impact, for papers by Toru Kita Breakdown of academic impact, for papers by Carol Kilkenny Breakdown of academic impact, for papers by Mauro Martins Teixeira Breakdown of academic impact, for papers by Hubert Kolb Breakdown of academic impact, for papers by Jing Liu Breakdown of academic impact, for papers by Prakash Nagarkatti Breakdown of academic impact, for papers by Steven B. Abramson
Rankless by CCL
2026